The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
Index/Startups & Founders/The Biotech Startups Podcast
The Biotech Startups Podcast artwork

🧬 From Games to Cancer Research: Why Drug Discovery Is an Economics Problem | Javier Tordable (3/4)

The Biotech Startups Podcast · 2026-07-27 · 23 min

0:00--:--

Episode notes

The Biotech Startups Podcast is powered by Excedr - helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr's partner network - special savings, promotions, and more. Explore these offers today: "Pessimists are often right, but optimists are often wealthy." In this part of the podcast, Jon and Javier explore Javier's years as technical director in Google's Office of the CTO, where he worked with the world's biggest gaming companies - Nintendo, Ubisoft, Electronic Arts, and Unity - helping them leverage Google Cloud technology. Javier then shares the deeply personal story of how his father's passing from cancer became the turning point that pulled him into life sciences, and how he taught himself biochemistry and pharmacology through Harvard Medical School's HMX program. The conversation takes a sharp turn into the economics of drug discovery and healthcare.

More from The Biotech Startups Podcast

All episodes →
  • 🧬 This Ex-Googler Replaced a Whole Drug R&D Team | Javier Tordable (4/4)82 / 100
  • 🧬 Transforming Food Systems with Lactoferrin & Precision Fermentation | Fengru Lin Rerelease (3/3)72 / 100
  • 🧬 AI in Biotech: When Sustainable Growth Replaces Hype | Mati Gill (4/4)60 / 100
  • 🧬 Venture Studio Model: Building the Future of AI Drug Discovery | Mati Gill (3/4)78 / 100
  • 🧬 From Law School to Teva: Learning a 45,000-Person Organization | Mati Gill (2/4)73 / 100
Explore the best B2B Startups & Founders podcasts →
All The Biotech Startups Podcast episodes →